American Association for Cancer Research
Browse
15417786mcr210301-sup-264651_2_supp_7241967_qvyh9l.xls (112.5 kB)

Supplementary Table 1 from The PI3K/mTOR Inhibitor Ompalisib Suppresses Nonhomologous End Joining and Sensitizes Cancer Cells to Radio- and Chemotherapy

Download (112.5 kB)
dataset
posted on 2023-04-03, 19:45 authored by Jie Du, Fuqiang Chen, Jiahua Yu, Lijun Jiang, Meijuan Zhou

Table S1. List of 28 hits from primary screen. The CAS No. and tradenames of each drug are also listed.

Funding

National Natural Science Foundation of China

China Postdoctoral Science Foundation

History

ARTICLE ABSTRACT

In summary, our findings suggested the possibility for repurposing these candidates as radio- or chemosensitizers, which might extend their clinical application in cancer therapy.